Collection of data

General information of collected datasets during cell state transitions:

Transitions
(Click to analyse)		 Technology
 		 Species
 		 Origin
cell		 Intermediate
time points		 Terminal
cell		 Induction
 		 Data
source
GSE32658.LSBmicroarrayHomo sapiensESCD1, D3, D5, D7, D11, D13, D25NeuronL(LDN193189(BMP inhibitor)), SB(SB431542 (TGF-b signal inhibitor))GSE32658
GSE32658.LSB.S.F8microarrayHomo sapiensESCD3, D5, D7, D11, D13, D25NeuronL(LDN193189(BMP inhibitor)), (SB431542 (TGF-b signal inhibitor)), S (SHH + Purmorphamine (Smo agonist)), F8 (FGF8) GSE32658
GSE32658.LSB.S.F8.CHIRmicroarrayHomo sapiensESCD5, D7, D11, D13, D25NeuronL(LDN193189(BMP inhibitor) , day 0-11), (SB431542 (TGF-b signal inhibitor), day 0-5), S (SHH + Purmorphamine (Smo agonist), day 1-7), F8 (FGF8, day 1-7) and CHIR (CHIR99021 (GSK3b inhibitor), day 3-13)GSE32658
GSE44303microarrayHomo sapiensMSCD0.021, D0.042, D0.083, D0.25, D0.5, D1, D1.5, D7, D14PreADPIBMX, indomethacin, dexamethasone, insulin; Lonza, PT-3102B/PT-4135GSE44303
GSE67152.D1.and.D2microarrayHomo sapiensESCD1, D2, D3, D4, D5, D6, D8CMBMP4, CHIR99021, Dorsomorphin, IWP-2 on days 1 and 2GSE67152
GSE67152.D2.and.D3microarrayHomo sapiensESCD1, D2, D3, D4, D5, D6, D8CMBMP4, CHIR99021, Dorsomorphin, IWP-2 on days 2 and 3GSE67152
GSE42094microarrayHomo sapiensESCD3, D7, D11, D15, D18Pancreatic Beta Islet CellAccording to D'Amour et al., 2006 with minor modifications: 1% BSA and 1% NEAA were added in the first 3 days of treatment to increase cell viability.GSE42094
GSE50206.MEFmicroarrayMus musculusMEFD3, D7, D11, D15, D20, D24iPSCOCT3/4, SOX2, KLF4, c-MYC and GLIS1GSE50206
GSE12985.E3.5microarrayMus musculusTSCD1, D2, D3, D4, D5, D6TSC_unknownwithdrawal of FGF4 heparin and feeder conditioned mediumGSE12985
GSE12985.E6.5microarrayMus musculusTSCD1, D2, D3, D4, D5, D6TSC_unknownwithdrawal of FGF4 heparin and feeder conditioned mediumGSE12985
GSE46532microarrayMus musculusMEFD11, D15, D19, D22, D26iPSCOct4,cMyc,Klf4GSE46532
GSE5671microarrayMus musculusESCD5, D6, D7, D8CMthrough EB formationGSE5671
GSE4818microarrayMus musculusESCD11, D12, D14, D16, D18Testisremoved from fetusesGSE4818
GSE5334microarrayMus musculusESCD11, D12, D14, D16, D18Ovaryremoved from fetusesGSE5334
GSE21278microarrayMus musculusESCE10, E11, E12, E13, E14, E15, E16, E17, E18Hypothalamusobtain from embryoGSE21278
GSE16992microarrayMus musculusMyoblastD0.021, D0.042, D0.063, D0.083, D0.125, D0.15, D0.375, D0.5, D1, D2, D4, D6MyotubeDMEM + 2% horse serumGSE16992
GSE6881microarrayMus musculusESCE11.5, E12.5, E14.5, E16.5, E18.5Testisobtain from embryoGSE6881
GSE6882microarrayMus musculusESCE11.5, E12.5, E14.5, E16.5, E18.5Ovaryobtain from embryoGSE6882
GSE36313.ESCmicroarrayMus musculusESCD0.125, D0.25, D0.5, D1, D2, D3Endoderm CellGata4GRGSE36313
GSE36313.MesodermmicroarrayMus musculusMesoderm CellD0.5, D1, D1.5, D2, D3Endoderm CellGata4GRGSE36313
GSE50206.HDFmicroarrayHomo sapiensHDFD3, D7, D11, D15, D20, D28, D35, D42, D49iPSCOCT3/4, SOX2 (IRES-EGFP), KLF4 and c-MYCGSE50206
GSE50206.ASCmicroarrayHomo sapiensASCD3, D7, D11, D20, D28iPSCOCT3/4, SOX2 (IRES-EGFP), KLF4 and c-MYCGSE50206
GSE50206.AstrocytemicroarrayHomo sapiensAstrocyteD3, D7, D11, D15, D20, D28, D35, D42iPSCOCT3/4, SOX2 (IRES-EGFP), KLF4 and c-MYCGSE50206
GSE50206.NHBEmicroarrayHomo sapiensNHBED3, D7, D11, D15, D28iPSCOCT3/4, SOX2 (IRES-EGFP), KLF4 and c-MYCGSE50206
GSE50206.PrECmicroarrayHomo sapiensPrECD3, D7, D11, D15, D28iPSCOCT3/4, SOX2 (IRES-EGFP), KLF4 and c-MYCGSE50206
GSE2154microarrayMus musculusEmbryo Limb BudD3, D6, D9, D12, D15Chondrocytebeta-glycerophosphate and ascorbic acidGSE2154
GSE75582microarrayHomo sapiensESCD8, D9, D12, D15NeuronImmature dorsal root ganglia neurons have been generated as described in Chambers SM, Qi Y, Mica Y, et al. Cryopreserved 8 days differentiated cells, then continue differentiation after thawingGSE75582
GSE10315.TGFb3microarrayHomo sapiensMSCD1, D3, D7, D21ChondrocyteTGFβ3GSE10315
GSE51533.PIPmicroarrayHomo sapiensESCD1, D3, D5, D7, D9, D11Neuroepithelial Celluse dual-SMAD inhibition protocol to differentiate towards CNS lineages then remove Noggin at day3 (PIP protocal)GSE51533
GSE51533.NSBmicroarrayHomo sapiensESCD1, D3, D5, D7, D9, D11Neuroepithelial CellN-SB protocolGSE51533
GSE14387microarrayMus musculusMyoblastD0.007, D0.014, D0.021, 0.042, D0.104, D0.15, D0.25Myotubedifferentiation medium (DMEM with 2% FBS, 2% Glutamax, 1% glucose and penicillin/streptomycin)GSE14387
GSE28191microarrayHomo sapiensiPSCD2, D5, D7, D9CMRPMI+B27 mediumGSE28191
GSE34551microarrayHomo sapiensESCD2, D3, D5, D7NeuronKSR media + N2 media(5d)GSE34551
GSE54766microarrayHomo sapiensiPSCD7, D14, D21, D28, D35MSCOCT3/4, SOX2, KLF4, and c-MYCGSE54766
GSE10469.O4percentmicroarrayHomo sapiensESCD0.125, D0.5, D1, D3, D5TrophoblastFGF2-,different oxygen conditions:4%GSE10469
GSE10469.O20percentmicroarrayHomo sapiensESCD0.125, D0.5, D1, D3, D5TrophoblastFGF2-,different oxygen conditions:20%GSE10469
GSE12531microarrayHomo sapiensESCD3, D5, D7, D10Primitive Hemangioblastserum free conditions in the presence of BMP4,VEGF,and FGF2GSE12531
GSE37761.O5percentmicroarrayHomo sapiensESCD0.5, D1, D5, D10, D15Endothelial Cell oxygen levels:1% using foreskin-fibroblast conditioned mediumGSE37761
GSE37761.O21percentmicroarrayHomo sapiensESCD0.5, D1, D5, D10, D15Endothelial Cell oxygen levels: 5% using foreskin-fibroblast conditioned mediumGSE37761
GSE37836microarrayHomo sapiensMSCD0.042, D0.5, D1, D2, D4, D6, D9, D12, D15AdipocyteAdipogenic induction medium( 2ml of human-insulin, 1ml of dexamethasone, and 0.4ml of indomethacin and 0.2ml of IBMX)GSE37836
GSE56988microarrayMus musculusNSCD1, D2, D4, D7Neurondifferentiation medium(DMEM/F12/N2 – Invitrogen, 2% FCS - Hyclone, 20 ng ml-1 bFGF, 35 μg ml-1 bovine pituitary extract – Peprotech)GSE56988
GSE19044.ESCmicroarrayMus musculusESCD2, D7, D14, D21, D28Hepatocytehepatic differentiation cocktail GSE19044
GSE46328microarrayHomo sapiensEPCD5, D7, D9, D13, D17Endothelial CellGSE46328
GSE41352microarrayHomo sapiensPreadipocyteD0.167, D0.333, D0.5, D1, D3, D12AdipocyteOF media(0.01 mg/ml human transferrin, 200 nM T3, 100 nM cortisol, 20 nM insulin, 500 microM IBMX and 100 nM rosiglitazone)GSE41352
GSE49987.MyeloidmicroarrayMus musculusFDCPD0.083, D0.167, D0.25, D0.333, D0.417, D0.5, D0.583, D0.667, D0.75, D0.833, D0.917, D1, D1.125, D1.25, D1.375, D1.5, D1.625, D1.75, D1.875, D2, D2.167, D2.333, D2.5, D2.667, D2.833, D3, D4, D5, D7MyeloidIMDM plus 10% FCS and low IL-3 supplemented with either Epo and SCFGSE49991
GSE49987.ErythroidmicroarrayMus musculusFDCPD0.083, D0.167, D0.25, D0.333, D0.417, D0.5, D0.583, D0.667, D0.75, D0.833, D0.917, D1, D1.125, D1.25, D1.375, D1.5, D1.625, D1.75, D1.875, D2, D2.167, D2.333, D2.5, D2.667, D2.833, D3, D4, D5, D7ErythroidIMDM plus 10% FCS and low IL-3 supplemented with either Epo and hemin or G-CSFGSE49991
GSE628microarrayMus musculusG1ED0.125, D0.292, D0.583, D0.875, D1.25ErythroblastEstradiolGSE628
GSE43955microarrayMus musculusT CellD0.021, D0.042, D0.083, D0.167, D0.25, D0.333, D0.417, D0.5, D0.667, D0.833, D1, D1.25, D1.75, D2, D2.083, D2.167, D2.5, D3Th172ng/mL rhTGF-β1 (Miltenyi Biotec), 25ng/mL rmIl-6 (Miltenyi Biotec), 20ng/ml rmIl-23 (Miltenyi Biotec), and 20ng/ml rmIL-β1 (Miltenyi Biotec)GSE43955
GSE43969microarrayMus musculusT CellD1, D2, D2.042, D2.25, D2.708, D3Th172ng/mL rhTGF-β1 (Miltenyi Biotec), 25ng/mL rmIl-6 (Miltenyi Biotec), 20ng/ml rmIl-23 (Miltenyi Biotec), and 20ng/ml rmIL-β1 (Miltenyi Biotec)GSE43969
GSE6932microarrayHomo sapiensEPCD0.5, D1, D1.5, D2NHEKPP-2 (compound 9)GSE6932
GSE5264.donor1microarrayHomo sapiensHBECD1, D2, D4, D8, D10, D12, D14, D17, D21, D28Mucociliary Cell500 nM retinoic acid was added to culture medium after cells reached 100% confluence to promote differentiation. Air-liquid interface (ALI) culture was initiated 48 hours later by removing the apical medium, and basolateral media containing 100nM retinoic acid was used for the ALI culture period.GSE5264
GSE5264.donor2microarrayHomo sapiensHBECD1, D2, D4, D8, D10, D12, D14, D17, D21, D28Mucociliary Cell500 nM retinoic acid was added to culture medium after cells reached 100% confluence to promote differentiation. Air-liquid interface (ALI) culture was initiated 48 hours later by removing the apical medium, and basolateral media containing 100nM retinoic acid was used for the ALI culture period.GSE5264
GSE5264.donor3microarrayHomo sapiensHBECD1, D2, D4, D8, D10, D12, D14, D17, D21, D28Mucociliary Cell500 nM retinoic acid was added to culture medium after cells reached 100% confluence to promote differentiation. Air-liquid interface (ALI) culture was initiated 48 hours later by removing the apical medium, and basolateral media containing 100nM retinoic acid was used for the ALI culture period.GSE5264
GSE1984microarrayMus musculusMyoblastD0.167, D0.5, D1, D2Myotubetrichostatin A(TSA)GSE1984
GSE69321microarrayMus musculusESCD0.5, D1, D1.5, D2, D4, D6Extroembryonic Endoderm Stem Cellshort pulse of Gata6 inductionGSE69321
GSE46321.withCEBPamicroarrayMus musculusB-cellD0.125, D0.25, D0.5, D1, D2, D4, D6, D8iPSCa pulse of C/EBPα in B cell precursors followed by OSKM expressionGSE46321
GSE46321.withoutCEBPamicroarrayMus musculusB-cellD0.125, D0.25, D0.5, D1, D2, D4, D6, D8iPSCa pulse of C/EBPα in B cell precursors followed by OSKM expressionGSE46321
GSE45223.Neural LineagemicroarrayHomo sapiensESCD1, D3, D6, D8, D11Neural LineageDual SMAD Inhibition (Dsi)GSE45223
GSE45223.NCmicroarrayHomo sapiensESCD1, D3, D6, D8, D11NCDual SMAD Inhibition (Dsi) + CHIR 99021GSE45223
GSE45223.MelanocytemicroarrayHomo sapiensESCD1, D3, D6, D8, D11MelanocyteDual SMAD Inhibition (Dsi) + CHIR99021 + BMP4 + EDN3GSE45223
GSE79146microarrayMus musculusMEFD3, D7, D14NeuronThe chemical compound forskolin combined with Ascl1GSE79146
GSE71528microarrayMus musculusESCD2, D4, D5, D6, D8, D10CMGrow as embryoid bodies, and transferred to tissue culture plates after 4.5 days [PMID:17360443]GSE71528
GSE28688microarrayHomo sapiensFibroblastD1, D2, D3iPSCOSKM transductionGSE28688
GSE11415microarrayMus musculusMyoblastD0.25, D1, D2, D3, D4, D5MyotubeCulture cells in medium containing reduced serum concentration (2% v/v) for up to 5 days with medium changes every 2 daysGSE11415
GSE72676microarrayHomo sapiensFibroblastD0.5, D0.7, D1, D1.2, D1.5, D1.7, D2, D2.2, D2.5, D2.7, D3.5, D3iPSCSOX2,OCT3/4,c-MYC,KLF4GSE72676
GSE67995microarrayHomo sapiensESCD1, D2, D3, D6, D10CMDifferentiation was induced upon replating cells on Matrigel-coated 24-well plates in a defined serum and serum albumin-free medium based on Knockout-DMEMGSE67995
GSE67154microarrayHomo sapiensESCD1, D2, D3, D4, D5, D6, D8CMFGF (F) + BMP (B) + WNT (W) treatment during the first 24 hoursGSE67995
GSE35103microarrayHomo sapiensT CellD0.021, D0.042, D0.083, D0.167, D0.25, D0.5, D1, D2, D3Th17IL6, IL1b and TGFbGSE35103
GSE17806microarrayMus musculusNeuronP7, P10, P15, P25, P40Postnatal Neuronobtain from different postnatal day(P) interneuronGSE17806
GSE14907microarrayMus musculusEmbryonic Sweat GlandE15.5, E16.5, E17.5, P1, P3, P5Postnatal Sweat Glandobtain from different days during embryogenesis and postnatal(P) footpadsGSE14907
GSE37558.MSCmicroarrayHomo sapiensMSCD2, D8, D12, D25OsteoblastOsteogenic differentiation medium: 5 mM beta-glycerophosphate, 100 nM dexamethasone, 0.1 mM Vitamin CGSE37558
GSE19236microarrayHomo sapiensMonocyteD0.25, D0.75, D1.125, D1.75, D2.125, D2.75Dendritic Cell20U/ml IL-4, 280U/ml GM-CSF and 10% FCSGSE19236
GSE11854microarrayHomo sapiensSomitogenesis1 hr, 2 hr, 3 hr, 4 hr, 5 hr, 6 hr, 7 hr, 8 hr, 9 hr, 10 hr, 11 hr, 12 hrSomitogenesisIn vitro model of somitogenesis using human fibroblastsGSE11854
GSE7536microarrayMus musculusEmbryonic Inner EarE9, E9.5, E10, E10.5.Cochlea, E11.Cochlea, E11.5.Cochlea, E12.Cochlea, E10.5.Vestibular organ, E11.Vestibular organ, E11.5.Vestibular organ, E12.Vestibular organ, E12.5.Cochlea, E13.Cochlea, E13.5.Cochlea, E14.Cochlea, E14.5.Cochlea, E15.Cochlea, E12.5.Utricle and 3 ampullae, E13.Utricle and 3 ampullae, E13.5.Utricle and 3 ampullae, E14.Utricle and 3 ampullae, E14.5.Utricle and 3 ampullae, E15.Utricle and 3 ampullae, E12.5.Saccule, E13.Saccule, E13.5.Saccule, E14.Saccule, E14.5.Saccule, E15.SacculeInner Earobtain from different days during embryonic inner ear developmentGSE7536
GSE43155microarrayMus musculusEmbryonic CorneaE14.5, E15.5, E17.5, P3, P7, P14, P28;(P:postnatal day)Corneaobtain from different days during cornea developmentGSE43155
GSE15585microarrayMus musculusEmbryonic Inner EarVOT-E36 cell, D1, D2, D4, D7, D14Inner EarNAGSE15585
GSE18290.HumanmicroarrayHomo sapiens1-cell2-cell, 4-cell, 8-cell, MorulaBlastocystobtain from embryoGSE18290
GSE18290.MousemicroarrayMus musculus1-cell2-cell, 4-cell, 8-cell, MorulaBlastocystobtain from embryoGSE18290
GSE41208microarrayHomo sapiensB-cellD3, D6, D13, D20, D41Plasma CellCD138+ Plasma cells sorted on CD138 and 7-AAD, generated in the upper compartment of a transwell system after 28 days of IL-6, IFN-α and supplemented media, with M2-10B4 in the lower compartment.GSE41208
GSE37558.VSMCmicroarrayHomo sapiensVSMCD2, D8, D12, D25OsteoblastOsteogenic differentiation medium: 5 mM beta-glycerophosphate, 100 nM dexamethasone, 0.1 mM Vitamin CGSE37558